Call to Action for Enhanced Equity and Inclusion in Cannabis Research

被引:7
|
作者
Martin-Willett, Renee [1 ]
Bidwell, L. Cinnamon [1 ,2 ]
机构
[1] Univ Colorado, Dept Psychol & Neurosci, 1777 Exposit Dr,Ste 171, Boulder, CO 80309 USA
[2] Univ Colorado, Inst Cognit Sci, Boulder, CO 80309 USA
关键词
cannabis; equity; marijuana; research methods; underrepresented groups;
D O I
10.1089/can.2020.0149
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: Policies regarding cannabis use are rapidly evolving in the United States as exemplified by the legalization of recreational use in 11 states and the District of Columbia. Previous cannabis-related laws, however, disproportionately targeted communities of color before legalization, and many argue new policies are not being developed with the input of minority stakeholders postlegalization. Given that biomedical research has also historically underrepresented communities of color, there is an obligation on the part of researchers now to actively work toward improving equity in cannabis research at a time when the field is rapidly expanding. This is particularly important for research concerning therapeutic uses of cannabis and risk liabilities. Objective: This article is a call to action to improve equity and inclusion in cannabis research design and practice. Specifically, it includes three recommendations focusing on (1) inclusiveness of recruitment, (2) improve demographic reporting in articles, and (3) strengthening publication requirements. Conclusion: These efforts will enhance the shared values and ethics of our field and improve the quality and validity of our research findings moving forward.
引用
收藏
页码:77 / 81
页数:5
相关论文
共 50 条
  • [21] Picture a data scientist: a call to action for increasing diversity, equity, and inclusion in the age of AI
    de Hond, Anne A. H.
    van Buchem, Marieke M.
    Hernandez-Boussard, Tina
    JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 2022, 29 (12) : 2178 - 2181
  • [22] Effects of historical inequity and institutional power on cannabis research: Moving toward equity and inclusion
    Martin-Willett, Renee
    Stanger, Madeline
    James, Wanda
    Bryan, Angela D.
    Bidwell, L. Cinnamon
    PNAS NEXUS, 2023, 2 (12):
  • [23] LUPUS VASCULOPATHY: A CALL TO ACTION FOR ENHANCED AWARENESS AND RESEARCH
    Saadeh, Aseel
    Sharma, Rhea
    Childs, John
    Kalra, Kartik
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2025, 85 (04)
  • [24] Call for more research on cannabis
    Charatan, FB
    BRITISH MEDICAL JOURNAL, 1997, 314 (7081): : 626 - 626
  • [25] A Call to Action to Enhance Justice, Equity, Diversity, and Inclusion in the Journal of Gerontology Series A: Medical Sciences
    Thorpe, Roland J., Jr.
    Odden, Michelle C.
    Lipsitz, Lewis A.
    JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2022, 77 (01): : 89 - 90
  • [26] Call to action: gender equity in neonatology
    Kerri Z. Machut
    Shazia Bhombal
    Marilyn Escobedo
    Jasmeet Kataria-Hale
    Alla Kushnir
    Krithika Lingappan
    Christiana N. Oji-Mmuo
    Lisa Owens
    Renate Savich
    Clara Song
    Rachel Wright
    Christiane E. L. Dammann
    Journal of Perinatology, 2022, 42 : 982 - 983
  • [27] Call to action: gender equity in neonatology
    Machut, Kerri Z.
    Bhombal, Shazia
    Escobedo, Marilyn
    Kataria-Hale, Jasmeet
    Kushnir, Alla
    Lingappan, Krithika
    Oji-Mmuo, Christiana N.
    Owens, Lisa
    Savich, Renate
    Song, Clara
    Wright, Rachel
    Dammann, Christiane E. L.
    JOURNAL OF PERINATOLOGY, 2022, 42 (07) : 982 - 983
  • [28] Transformative Action for Diversity, Equity, and Inclusion
    Murphy, Brian R.
    FISHERIES, 2021, 46 (06) : 259 - 260
  • [29] Call to Action for Enhanced Equity: Racial/Ethnic Diversity and Sex Differences in Stroke Symptoms
    Hosman, Floortje L.
    Engels, Sabine
    den Ruijter, Hester M.
    Exalto, Lieza G.
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [30] Cannabis use and psychosis susceptibility: A call to action
    Batalla, Albert
    Maat, Arija
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2022, 54 : 70 - 71